Creative Medical Technology Holdings, Inc.
CELZ
$1.22
-$0.02-1.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -78.57% | -45.45% | -45.45% | -64.71% | 55.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -78.57% | -45.45% | -45.45% | -64.71% | 55.56% |
| Cost of Revenue | -82.14% | -50.00% | -45.45% | -64.71% | 55.56% |
| Gross Profit | -76.19% | -42.42% | -45.45% | -64.71% | 55.56% |
| SG&A Expenses | 8.90% | 16.18% | 16.79% | 7.15% | -0.13% |
| Depreciation & Amortization | 8.77% | 11.58% | 1.41% | 5.70% | 10.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.57% | 6.85% | 7.94% | -2.55% | 11.63% |
| Operating Income | 5.41% | -6.95% | -8.04% | 2.37% | -11.56% |
| Income Before Tax | 5.41% | -9.13% | -12.10% | -0.59% | -15.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.41% | -9.13% | -12.10% | -0.59% | -15.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.39% | -9.13% | -12.10% | -0.59% | -15.42% |
| EBIT | 5.41% | -6.95% | -8.04% | 2.37% | -11.56% |
| EBITDA | 5.67% | -6.85% | -8.18% | 2.52% | -11.57% |
| EPS Basic | 45.92% | 32.37% | 24.47% | 22.87% | -0.70% |
| Normalized Basic EPS | 45.91% | 32.36% | 24.47% | 22.87% | -0.70% |
| EPS Diluted | 45.92% | 32.37% | 24.47% | 22.87% | -0.70% |
| Normalized Diluted EPS | 45.91% | 32.36% | 24.47% | 22.87% | -0.70% |
| Average Basic Shares Outstanding | 78.16% | 65.93% | 57.93% | 35.76% | 14.83% |
| Average Diluted Shares Outstanding | 78.16% | 65.93% | 57.93% | 35.76% | 14.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |